The RET/PTC oncogene is frequently activated in oncocytic thyroid tumors (Hurthle cell adenomas and carcinomas), but not in oncocytic hyperplastic lesions

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 1, 2002, Pages 364-369

  Chiappetta, Gennaro ^a   Toti, Paolo ^b   Cetta, Francesco ^b   Giuliano, Ada ^c   Pentimalli, Francesca ^d   Amendola, Ida ^a   Lazzi, Stefano ^b   Monaco, Mario ^b   Mazzuchelli, Luca ^b   Tosi, Piero ^a   Santoro, Massimo ^d   Fusco, Alfredo ^a,e  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d UNIVERSITY OF BERN   (Switzerland)

^e UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN RET;

ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; GENE ACTIVATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ONCOCYTOMA; ONCOGENE RET; PRIORITY JOURNAL; THYROID HYPERPLASIA; THYROID TUMOR;

EID: 0036149992     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.87.1.8180     Document Type: Article

References (44)

1. The WHO histological classification of thyroid tumors: A commentary on the second edition
2. The aetiology of thyroid tumours
3. Tumors of the thyroid gland
4. Cytogenetics and molecular genetics of carcinomas arising from thyroid epithelial follicular cells
5. Human thyroid carcinogenesis
6. Pax8-PPARgamma1 fusion in oncogene human thyroid carcinoma
7. PTC is a novel rearranged form of the RET proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas
8. RET oncogene activation in human thyroid neoplasms is restricted to the papillary carcinoma subtype
9. Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of RET tyrosine kinase and the regulatory subunit RI alpha of cyclic AMP-dependent protein kinase A
10. Molecular characterization of RET/PTC3: A novel rearranged version of the RET proto-oncogene in a human thyroid papillary carcinoma
11. Frequent activation of RET protooncogene by fusion with a new activating gene in papillary thyroid carcinomas
12. Molecular and biochemical analysis of RET/PTC4, a novel oncogenic rearrangement between RET and ELE1 genes, in a post-Chernobyl papillary thyroid cancer
13. Detection of a novel type of RET rearrangement (PTC5) in thyroid carcinomas after Chernobyl and analysis of the involved RET-fused gene RFG5
14. The transcription coactivator HTIF1 and a related protein are fused to the RET receptor tyrosine kinase in childhood papillary thyroid carcinomas
15. Protein, nucleotide RET/PCM-1: A novel fusion gene in papillary thyroid carcinoma
16. The TRK and RET tyrosine kinase oncogenes cooperate with ras in the neoplastic transformation of a rat thyroid epithelial cell line
17. Expression of the RET/PTC1 oncogene impairs the activity of TTF-1 and Pax-8 thyroid transcription factors
18. Targeted expression of the RET/PTC1 oncogene induces papillary thyroid carcinomas
19. Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic trdce
20. The RET/PTC3 oncogene: Metastatic solid-type papillary carcinomas in murine thyroids
21. RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes
22. Sporadic RET-rearranged papillary carcinoma of the thyroid: A subset of slow growing, less aggressive thyroid neoplasms?
23. RET/PTC-1, -2, and -3 oncogene rearrangements in human thyroid carcinomas: Implications for metastatic potential?
24. RET oncogene activation in papillary thyroid carcinoma: Prevalence and implications on the histological parameters
25. RET/PTC oncogene activation is an early event in thyroid carcinogenesis
26. Activated RET oncogene in thyroid cancers of children from areas contaminated by Chernobyl accident
27. Oncogenic rearrangements of the RET proto-oncogene in papillary thyroid carcinomas from children exposed to the Chernobyl nuclear accident
28. High prevalence of RET rearrangement in thyroid tumors of children from Belarus after the Chernobyl reactor accident
29. Distinct patterns of RET rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children
30. Distinct frequency of RET rearrangements in papillary thyroid carcinoma of children and adults from Belarus
31. RET protooncogene rearrangement in thyroid cancer around Semipalatinsk nuclear testing site
32. High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: A strong correlation between RET/PTC3 and the solid-follicular variant
33. Gene rearrangement and Chernobylrelated thyroid cancers
34. Pattern of radiation-induced RET and NTRK1 rearrangements in 191 post-Chernobyl papillary thyroid carcinomas: Biological, phenotypic, and clinical implications
35. High prevalence of activating RET proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation
36. RET/PTC and RET tyrosine kinase expression in adult papillary thyroid carcinomas
37. RET/PTC activation in hyalinizing trabecular tumors of the thyroid
38. Hyalinizing trabecular tumor of the thyroid: A variant of papillary carcinoma proved by molecular genetics
39. Molecular basis of Hurthle cell papillary thyroid carcinoma
40. Oncocytic (Hurtle cells) tumors of the thyroid: Distinct growth patterns compared with clinicopathological features
41. Interphase cytogenetics in oncocytic adenomas and carcinomas of the thyroid gland
42. A new human species of aldolase A mRNA from fibroblasts
43. RET receptor expression in thyroid follicular epithelial cell-derived tumors